Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy

In recent decades, a new method of cellular immunotherapy was introduced based on engineering and empowering the immune effector cells. In this type of immunotherapy, the immune effector cells are equipped with chimeric antigen receptor (CAR) to specifically target cancer cells. In much of the trial...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cell Res Ther
Autori principali: Marofi, Faroogh, Rahman, Heshu Sulaiman, Thangavelu, Lakshmi, Dorofeev, Aleksey, Bayas-Morejón, Favian, Shirafkan, Naghmeh, Shomali, Navid, Chartrand, Max Stanley, Jarahian, Mostafa, Vahedi, Ghasem, Mohammed, Rebar N., Shahrokh, Somayeh, Akbari, Morteza, Khiavi, Farhad Motavalli
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983395/
https://ncbi.nlm.nih.gov/pubmed/33752707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-021-02251-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi